The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study
Toxicology Research · 31.12.2024 · 14 (1)
DOI: 10.1093/toxres/tfaf007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 17.01.2025. Verfasst von Rana Khairi Attarbashee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Basic Sciences, College of Dentistry, University of Mosul, Majmoaa Thqafiya St., Mosul 41002, +964, Iraq. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Methotrexate (MTX) is an antimetabolite drug utilized for managing a variety of cancers and autoinflammatory conditions. MTX may trigger detrimental effects in mout, h tissues, including salivary gland impairment. Bosentan (BOS), a drug that blocks endothelin receptors, has strengthened antioxidant, anti-inflammatory, and anti-apoptotic properties. The study aimed to estimate the protective effect of BOS on MTX-exacerbated salivary changes in Wistar Albino rats. Thirty male rats were arbitrarily sorted into three groups of ten animals each. The control group received a normal saline for 18 days. The MTX (induction) group received MTX (25 mg/kg) intraperitoneally on the 7th day of the experiment once daily for 6 consecutive days. The MTX + BOS group received BOS (50 mg/kg) orally once a day for 18 days: 6 days before induction, 6 days 2-h after induction, and 6 days post-induction. Animals were euthanized on day 19, and salivary gland tissues were dissected for biochemical, histopathological, and immunohistochemical analyses. BOS dramatically improved MTX-aggravated biochemical and histopathological abnormalities, as evidenced by diminished Bax, caspase 3, TNF-α, IL-1β, MDA, and MPO levels, increased SOD, GSH, and GPX levels, and reduced degenerative changes in the granular convolute tubule, mucous acini, and striate duct. BOS further substantially upregulated MTX-induced decline of the Ki-67 and Bcl-2, as indicated by immunohistochemistry scoring methods. The anti-oxidative, ant-inflammatory, and antiapoptotic properties of BOS are a promising strategy for ameliorating the toxic effect of MTX on submandibular glandular tissues.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dental Basic Sciences, College of Dentistry, University of Mosul, Majmoaa Thqafiya St., Mosul 41002, +964, Iraq.
- College of Pharmacy, Al-Mustaqbal University, Babylon Province, Najaf Road, Hillah 51001, +964, Iraq.
ORCID-Profile: Rana Khairi Attarbashee, Heba Faiz Hamodat, Jawnaa Khalid Mammdoh, Hayder Ridha-Salman
Zitieren
APA
Attarbashee, R. K., Hamodat, H. F., Mammdoh, J. K., & Ridha-Salman, H. (2024). The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study. Toxicology Research, 14(1). https://doi.org/10.1093/toxres/tfaf007
Vancouver
Attarbashee RK, Hamodat HF, Mammdoh JK, Ridha-Salman H. The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study. Toxicology Research. 2024;14(1). doi:10.1093/toxres/tfaf007
BibTeX
@article{Attarbashee2024,
author = {Attarbashee, Rana Khairi and Hamodat, Heba Faiz and Mammdoh, Jawnaa Khalid and Ridha-Salman, Hayder},
title = {The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study},
journal = {Toxicology Research},
year = {2024},
volume = {14},
number = {1},
doi = {10.1093/toxres/tfaf007}
}
EUVIMED